A Study on Voluntary Routine COVID-19 Self-testing in Mizoram, India.
NCT05614388 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 646
Last updated 2022-11-21
Summary
This interventional study aims to evaluate the utilization, adherence, and acceptability of voluntary, free, routine self-testing for COVID-19 (Corona Virus (19) Disease) and related information, education and communication (IEC) messages in two institutional settings in Mizoram, India. In addition, it will assess and measure preferences for assisted vs unassisted and observed vs unobserved self-testing, assess adherence and measure dropout rate and describe dropout characteristics.
The research questions it aims to address are -
1. What is the uptake and adherence of voluntary, free, routine self-testing for COVID-19 and related IEC messages vy students, employees, and healthcare workers in two institutional settings in India? Are there any dropouts from routine self-testing and what are the factors related to dropouts?
2. What is the preferred mode of self-testing- observed or unobserved, assisted or unassisted? Do these preferences change over time? The researchers will be measuring - Utilization rate, Adherence rate, Proportion of preference to assisted vs unassisted self-testing, Proportion of preference to observed vs unobserved self-testing, Time to dropout and Acceptability of COVID-19 self-testing kits.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
COVID-19 Self testing and related messaging
Provisioning of voluntary, free self-testing for COVID-19 (approved and validated in the country) and related Information, Education and Communication (IEC) messages
Sponsors & Collaborators
-
UNITAID
collaborator OTHER -
Zoram Medical College (ZMC)
collaborator UNKNOWN -
Pacchunga University College
collaborator UNKNOWN -
Association for Leprosy Education Rehabilitation & Treatment India (ALERT India)
collaborator UNKNOWN -
Government of Mizoram
collaborator UNKNOWN -
PATH
lead OTHER
Principal Investigators
-
Jane Ralte, MD · Zoram Medical College
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-31
- Primary Completion
- 2023-04-30
- Completion
- 2023-05-31
More Related Trials
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients
NCT05246072 ·Status: COMPLETED ·Phase: PHASE4
-
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
NCT00121823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
101-PGC-005 for the Treatment of COVID-19
NCT05656521 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Assess the Effect of Meplazumab on COVID-19
NCT04586153 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria
NCT02118428 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria Parasites
NCT00890760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01218893 ·Status: COMPLETED ·Phase: NA
-
Malaria Challenge in Healthy Volunteers
NCT01500980 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
NCT00600548 ·Status: COMPLETED ·Phase: PHASE2
-
Malaria Molecular Surveillance in Mozambique (Phase 2)
NCT06529237 ·Status: RECRUITING
-
Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults
NCT03420053 ·Status: COMPLETED ·Phase: PHASE1
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
NCT02639299 ·Status: RECRUITING
-
Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
NCT00682656 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis
NCT01422954 ·Status: COMPLETED ·Phase: NA
-
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
NCT00480883 ·Status: COMPLETED ·Phase: NA
-
Rickettsiae in Myanmar
NCT03847870 ·Status: COMPLETED
-
A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S
NCT01883609 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali
NCT02206451 ·Status: COMPLETED
-
Diagnosis and Treatment of Leishmania Infections
NCT00344188 ·Status: RECRUITING
-
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
NCT00604955 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum
NCT06040346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Two New Malaria Vaccines
NCT01003314 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
NCT00255567 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
NCT00486382 ·Status: COMPLETED ·Phase: PHASE1